Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + Chemotherapy in Metastatic Colorectal Cancer
NCT01564810Phase 4Unknown
- Start
- Sep 2006
- Primary completion
- Jun 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of KL-140 in colorectal cancer (CRC) and liver metastasis. Status: unknown.
02
Drugs
KL-140
03
Conditions
colorectal cancer (CRC)liver metastasis
Beyond the preview
Go deeper on NCT01564810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01564810.